| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-16 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-16 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-16 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-13 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-12 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-12 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |